Your session is about to expire
← Back to Search
N/A
Psychophysics of Sequential Biases in Vision
N/A
Recruiting
Led By David Whitney, PhD
Research Sponsored by University of California, Berkeley
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Subjects must have normal or corrected to normal vision with contacts or glasses.
Be older than 18 years old
Must not have
Subjects must not be under the age of 18 to participate.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up each participant is tested for 30-60 minutes in a psychophysical experiment.
Awards & highlights
No Placebo-Only Group
Summary
This trial will study the effects of serial dependencies on radiologists' ability to correctly detect and classify tumors in X-rays.
Who is the study for?
This trial is for individuals with normal or corrected-to-normal vision, such as those who wear glasses or contacts. It's designed to help radiologists improve their ability to detect and classify tumors in x-rays by understanding how previous images they've seen can affect their current work.
What is being tested?
The study investigates how past visual experiences bias a radiologist's perception and decisions when examining sequential x-rays. The goal is to establish these biases, identify conditions that influence them, and develop strategies to mitigate their negative effects on tumor detection and classification.
What are the potential side effects?
Since this trial involves no drugs but focuses on the psychophysics of visual perception, there are no traditional side effects associated with medication. However, participants may experience eye strain or fatigue from viewing multiple x-ray images.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My vision is normal or corrected to normal with glasses or contacts.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ each participant is tested for 30-60 minutes in a psychophysical experiment.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~each participant is tested for 30-60 minutes in a psychophysical experiment.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Serial Dependence Assessment using psychophysical procedures
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Healthy Typical AdultsExperimental Treatment1 Intervention
Observers including radiologists and non-radiologists will be asked to participate in computer based tasks in which they visually search for, detect, localize, and categorize tumors in x-ray images.
Find a Location
Who is running the clinical trial?
University of California, BerkeleyLead Sponsor
187 Previous Clinical Trials
639,326 Total Patients Enrolled
David Whitney, PhD4.9126 ReviewsPrincipal Investigator - University of California, Berkeley
Hackensack University Medical Center
Medical School - Touro College and University System, Doctor of Osteopathic Medicine
Hackensack University Medical Center, Residency in Family Medicine
5Patient Review
I had an amazing experience!!!
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.My vision is normal or corrected to normal with glasses or contacts.
Research Study Groups:
This trial has the following groups:- Group 1: Healthy Typical Adults
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.